Manulife (Manufacturers Life Insurance)
RPTX

Manulife (Manufacturers Life Insurance)’s Repare Therapeutics RPTX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13,183
Closed -$179K – 2990
2022
Q2 		$179K Sell
13,183
-13,184
-50% -$155K ﹤0.01% 2713
2022
Q1 		$380K Buy
+26,367
New +$391K ﹤0.01% 2359

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s RPTX Position: Q3 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Repare Therapeutics (RPTX) in Q3 2022, closing a stake of 13,183 shares — an estimated $179K sold.

Manulife (Manufacturers Life Insurance) first reported a position in RPTX in Q1 2022 and held it in 2 quarters. The position peaked at $380K in Q1 2022. 71 funds tracked by Wall St. Rank hold RPTX as of Q3 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining Repare Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 13,183 Repare Therapeutics shares in Q3 2022, an estimated $179K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Repare Therapeutics in Q1 2022 and held it in 2 quarters.
  • Manulife (Manufacturers Life Insurance)'s Repare Therapeutics position peaked at $380K in Q1 2022.
  • 71 funds tracked by Wall St. Rank held Repare Therapeutics as of Q3 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2022, filed 3 Nov 2022.